I-MAB - American Depositary Shares (IMAB)
2.0000
-0.0300 (-1.48%)
NASDAQ · Last Trade: Jul 31st, 9:58 AM EDT
Detailed Quote
Previous Close | 2.030 |
---|---|
Open | 2.030 |
Bid | 2.000 |
Ask | 2.050 |
Day's Range | 1.940 - 2.035 |
52 Week Range | 0.5950 - 3.075 |
Volume | 69,211 |
Market Cap | 371.23M |
PE Ratio (TTM) | -16.67 |
EPS (TTM) | -0.1 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 373,167 |
Chart
About I-MAB - American Depositary Shares (IMAB)
I-Mab is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative T-cell engagers and monoclonal antibodies for the treatment of cancer and autoimmune diseases. The company leverages its proprietary technology platform to create therapies that target specific biological pathways, aiming to address unmet medical needs in oncology. With a strong emphasis on research and collaboration, I-Mab works to bring advanced therapies to patients worldwide, enhancing treatment options and outcomes in the field of medicine. Read More
News & Press Releases
Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.
Via Chartmill · July 30, 2025
Via Benzinga · July 30, 2025
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · July 30, 2025
Via Benzinga · July 2, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · June 27, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 27, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via Chartmill · June 3, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via Chartmill · June 3, 2025
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · April 14, 2025
Via Benzinga · April 7, 2025
Via Benzinga · April 4, 2025
Via Benzinga · April 4, 2025

Via Benzinga · October 2, 2024

It was a quiet week for biotech news in the Chinese market. Here is a brief overview of the notable events that occurred during this time. Zenas BioPharma staged a rare US biopharma IPO worth $259 million to complete development of its product.
Via Talk Markets · September 28, 2024

Structure Therapeutics announced positive clinical results for its obesity drug, and then raised $476 million via an offering of its ADSs. Meanwhile, Alphamab Oncology announced a deal with ArriVent BioPharma.
Via Talk Markets · June 8, 2024

Via Benzinga · June 5, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · March 18, 2024